Harris Associates’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-2,200
Closed -$307K 133
2017
Q4
$307K Buy
+2,200
New +$306K ﹤0.01% 128
2015
Q3
Sell
-14,134
Closed -$1.38M 129
2015
Q2
$1.38M Sell
14,134
-3,244
-19% -$325K ﹤0.01% 125
2015
Q1
$1.75M Sell
17,378
-1,690
-9% -$172K ﹤0.01% 130
2014
Q4
$1.99M Buy
19,068
+370
+2% +$39K ﹤0.01% 139
2014
Q3
$1.99M Hold
18,698
﹤0.01% 134
2014
Q2
$1.96M Sell
18,698
-300
-2% -$30.3K ﹤0.01% 136
2014
Q1
$1.87M Buy
18,998
+300
+2% +$27.8K ﹤0.01% 135
2013
Q4
$1.71M Hold
18,698
﹤0.01% 142
2013
Q3
$1.62M Hold
18,698
﹤0.01% 140
2013
Q2
$1.6M Buy
+18,698
New +$1.59M ﹤0.01% 146

Other funds holding JNJ

Harris Associates's JNJ Position: Q1 2018 in Review

Harris Associates sold out of Johnson & Johnson (JNJ) in Q1 2018, closing a stake of 2,200 shares — an estimated $307K sold.

Harris Associates first reported a position in JNJ in Q2 2013 and held it in 10 quarters. The position peaked at $1.99M in Q4 2014. 2,597 funds tracked by Wall St. Rank hold JNJ as of Q1 2018.

  • Harris Associates reported no remaining Johnson & Johnson position as of Q1 2018 after selling out during the quarter.
  • Harris Associates sold 2,200 Johnson & Johnson shares in Q1 2018, an estimated $307K.
  • Harris Associates first reported a position in Johnson & Johnson in Q2 2013 and held it in 10 quarters.
  • Harris Associates's Johnson & Johnson position peaked at $1.99M in Q4 2014.
  • 2,597 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2018.

Based on Harris Associates's 13F filing for Q1 2018, filed 15 May 2018.